Skip to main content

Published locations for Trastuzumab deruxtecan proves active in HER2-mutated NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Trastuzumab deruxtecan proves active in HER2-mutated NSCLC

User login

  • Reset your password
  • /content/trastuzumab-deruxtecan-proves-active-her2-mutated-nsclc
  • /internalmedicinenews/article/223050/lung-cancer/trastuzumab-deruxtecan-proves-active-her2-mutated
  • /oncologypractice/article/223050/lung-cancer/trastuzumab-deruxtecan-proves-active-her2-mutated-nsclc
  • /jcomjournal/article/223050/lung-cancer/trastuzumab-deruxtecan-proves-active-her2-mutated-nsclc
  • /hematology-oncology/article/223050/lung-cancer/trastuzumab-deruxtecan-proves-active-her2-mutated
  • /internalmedicine/article/223050/lung-cancer/trastuzumab-deruxtecan-proves-active-her2-mutated-nsclc
  • /chestphysician/article/223050/lung-cancer/trastuzumab-deruxtecan-proves-active-her2-mutated-nsclc